| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |